POZ-buprenorphine conjugate (Serina Therapeutics)

N/A

Report date: 2025/06/11 11:19:52
NME

Base Information

Drug NamePOZ-buprenorphine conjugate (Serina Therapeutics)
Drug Alias NamePOZ-polymer conjugated therapeutic (Serina Therapeutics)polyoxazoline -polymer conjugated therapeutic (Serina Therapeutics)SER-226SER-227
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOpioid-Related DisordersPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSerina Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSerina Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsOpioid-Related DisordersPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A